Immunological Basis of Vaccine Adjuvants: From Licensed Platforms to Next-Generation Design.

Kim SH, Kim DJ, Jang YS

DOI: 10.4110/in.2026.26.e37
Published: 2026 Oct
Container: Immune network
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4110/in.2026.26.e37,
  title = {Immunological Basis of Vaccine Adjuvants: From Licensed Platforms to Next-Generation Design.},
  author = {Kim SH and Kim DJ and Jang YS},
  year = {2026},
  journal = {Immune network},
  doi = {10.4110/in.2026.26.e37},
  url = {https://doi.org/10.4110/in.2026.26.e37}
}

RIS

TY  - JOUR
TI  - Immunological Basis of Vaccine Adjuvants: From Licensed Platforms to Next-Generation Design.
AU  - Kim SH
AU  - Kim DJ
AU  - Jang YS
PY  - 2026
JO  - Immune network
DO  - 10.4110/in.2026.26.e37
UR  - https://doi.org/10.4110/in.2026.26.e37
ER  -

APA

SH, K., DJ, K., & YS, J. (2026). Immunological Basis of Vaccine Adjuvants: From Licensed Platforms to Next-Generation Design.. Immune network. https://doi.org/10.4110/in.2026.26.e37

Source records

pubmed · retrieved 2026-11-10T06:53:08.399Z